Literature DB >> 7473077

Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking.

M A Milad1, E A Ludwig, S Anné, E Middleton, W J Jusko.   

Abstract

The circadian pattern of the immune system correlates with that of circulating T-helper cells and inversely with cortisol concentrations. Corticosteroids, both endogenous and exogenous, cause lymphocyte dimunition in blood by retention of cells in the lymphatic circulation. A physiologic pharmacodynamic model was developed to describe changes in circulating lymphocytes as a function of both endogenous cortisol and methylprednisolone concentrations. The model was applied to T-helper and T-suppressor cell data collected from six asthmatic men during baseline, after single-dose, and after 6 days of 20 mg daily methylprednisolone. The model described all phases of the study well. Baseline circadian rhythm of lymphocytes was related to cortisol concentrations. Multiple-dosing of methylprednisolone caused apparent tolerance and decreased the sensitivity of lymphocytes to corticosteroids by 116% and markedly reduced endogenous cortisol concentrations. A 60% increase in circulating T-helper cells was observed which could be accounted for by dual changes in receptor sensitivity and endogenous cortisol.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7473077     DOI: 10.1007/bf02353790

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  19 in total

Review 1.  The sensation and regulation of interactions with the extracellular environment: the cell biology of lymphocyte adhesion receptors.

Authors:  T A Springer
Journal:  Annu Rev Cell Biol       Date:  1990

2.  Circadian rhythmicity of human plasma cortisol and PHA-induced lymphocyte transformation.

Authors:  H B Tavadia; K A Fleming; P D Hume; H W Simpson
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

3.  The migration of lymphocytes across specialized vascular endothelium. IV. Prednisolone acts at several points on the recirculation pathways of lymphocytes.

Authors:  J H Cox; W L Ford
Journal:  Cell Immunol       Date:  1982-01-15       Impact factor: 4.868

4.  Circadian changes of T lymphocyte subsets in human peripheral blood.

Authors:  T Miyawaki; K Taga; T Nagaoki; H Seki; Y Suzuki; N Taniguchi
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

5.  Studies of the bioperiodicity of the immune response. II. Co-variations of murine T and B cells and a role of corticosteroid.

Authors:  T Kawate; T Abo; S Hinuma; K Kumagai
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

6.  Pharmacoimmunodynamics of methylprednisolone: trafficking of helper T lymphocytes.

Authors:  L E Fisher; E A Ludwig; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1992-08

7.  Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm.

Authors:  L E Fisher; E A Ludwig; J A Wald; R R Sloan; E Middleton; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1992-06       Impact factor: 6.875

8.  Analysis of cortisol, methylprednisolone, and methylprednisolone hemisuccinate. Absence of effects of troleandomycin on ester hydrolysis.

Authors:  W F Ebling; S J Szefler; W J Jusko
Journal:  J Chromatogr       Date:  1984-02-10

9.  Kinetics of cocaine distribution, elimination, and chronotropic effects.

Authors:  M J Chow; J J Ambre; T I Ruo; A J Atkinson; D J Bowsher; M W Fischman
Journal:  Clin Pharmacol Ther       Date:  1985-09       Impact factor: 6.875

10.  CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status.

Authors:  C J Corrigan; A B Kay
Journal:  Am Rev Respir Dis       Date:  1990-04
View more
  19 in total

1.  Pharmacokinetic/pharmacodynamic modeling of total lymphocytes and selected subtypes after oral budesonide.

Authors:  Jeffrey G Stark; Sybille Werner; Susanne Homrighausen; Yufei Tang; Michael Krieg; Hartmut Derendorf; Helmut Moellmann; Guenther Hochhaus
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-04-22       Impact factor: 2.745

Review 2.  Assessment of non-linear combination effect terms for drug-drug interactions.

Authors:  Gilbert Koch; Johannes Schropp; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-09-16       Impact factor: 2.745

3.  Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in rabbits.

Authors:  G M Ferron; W J Jusko
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

Review 4.  Characteristics of indirect pharmacodynamic models and applications to clinical drug responses.

Authors:  A Sharma; W J Jusko
Journal:  Br J Clin Pharmacol       Date:  1998-03       Impact factor: 4.335

5.  Characterization of four basic models of indirect pharmacodynamic responses.

Authors:  A Sharma; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1996-12

6.  Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone.

Authors:  F S Chow; A Sharma; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1999-12

Review 7.  Pharmacokinetic/pharmacodynamic modeling in inflammation.

Authors:  Hoi-Kei Lon; Dongyang Liu; William J Jusko
Journal:  Crit Rev Biomed Eng       Date:  2012

8.  Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.

Authors:  Y N Sun; D C DuBois; R R Almon; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1998-06

Review 9.  The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease.

Authors:  A Sasha Tait; Cherie L Butts; Esther M Sternberg
Journal:  J Leukoc Biol       Date:  2008-07-29       Impact factor: 4.962

10.  Interactions of prednisolone and other immunosuppressants used in dual treatment of systemic lupus erythematosus in lymphocyte proliferation assays.

Authors:  Mohamed A Kamal; William J Jusko
Journal:  J Clin Pharmacol       Date:  2004-09       Impact factor: 3.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.